Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q6)Feb 28, 2025 | (FY)Aug 31, 2024 | (Q6)Feb 29, 2024 | (FY)Aug 31, 2023 | (Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 641.06%215.83M | ---- | 102.37%29.13M | ---- | -272.89%-1.23B | ---- | 118.96%712.22M | ---- | 253.16%325.27M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 9.26%-8.73M | ---- | -8.72%-9.63M | ---- | -209.87%-8.85M | ---- | -29.86%-2.86M | ---- | 33.07%-2.2M | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | -99.82%128K | ---- | 42.58%70.33M | ---- | 56.56%49.33M | ---- | 12,919.83%31.51M | ---- |
| Impairment and provisions: | ---- | ---- | ---- | ---- | 14,707.50%1.2B | ---- | 179.45%8.1M | ---- | -65.71%2.9M | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | -45.48%1.58M | ---- | 133.87%2.9M | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | --1.2B | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | --6.52M | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.27%309K | ---- |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.27%309K | ---- |
| Asset sale loss (gain): | 79.81%-3.77M | ---- | -141.29%-18.67M | ---- | 81.36%-7.74M | ---- | -6,386.67%-41.49M | ---- | 534.62%660K | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | 159.31%3.72M | ---- | 84.35%-6.26M | ---- | ---40.03M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 83.94%-3.6M | ---- | -3,732.36%-22.38M | ---- | 59.97%-584K | ---- | -276.42%-1.46M | ---- | -83.08%827K | ---- |
| -Loss (gain) from selling other assets | ---174K | ---- | ---- | ---- | ---888K | ---- | ---- | ---- | 97.26%-167K | ---- |
| Depreciation and amortization: | -4.37%1.19B | ---- | -5.91%1.25B | ---- | -21.74%1.33B | ---- | -8.55%1.7B | ---- | -5.99%1.86B | ---- |
| -Depreciation | -2.21%822.21M | ---- | -6.66%840.83M | ---- | -3.53%900.82M | ---- | -7.71%933.83M | ---- | 3.86%1.01B | ---- |
| -Amortization of intangible assets | -8.81%372.38M | ---- | -4.33%408.34M | ---- | -10.25%426.81M | ---- | -14.55%475.57M | ---- | -22.33%556.53M | ---- |
| -Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | 0.12%287.08M | ---- | 1.43%286.74M | ---- |
| Financial expense | -17.41%710.44M | ---- | 22.49%860.24M | ---- | 193.60%702.3M | ---- | -50.27%239.2M | ---- | -8.72%481.03M | ---- |
| Exchange Loss (gain) | -111.85%-1.44M | ---- | 244.97%12.12M | ---- | -48.53%-8.36M | ---- | -137.53%-5.63M | ---- | 156.98%15M | ---- |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | -50.51%145K | ---- | -98.18%293K | ---- |
| Operating profit before the change of operating capital | -0.73%2.11B | ---- | 3.84%2.12B | ---- | -23.03%2.04B | ---- | -2.01%2.66B | ---- | 4.00%2.71B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 1,917.75%13.42M | ---- | -111.42%-738K | ---- | 122.81%6.46M | ---- | -495.15%-28.32M | ---- | 1,204.47%7.17M | ---- |
| Accounts receivable (increase)decrease | 178.72%63.59M | ---- | -170.04%-80.79M | ---- | 322.79%115.35M | ---- | -82.38%27.28M | ---- | 538.96%154.8M | ---- |
| Accounts payable increase (decrease) | -122.74%-21.13M | ---- | -4.43%92.9M | ---- | 135.74%97.22M | ---- | -2,193.38%-272.02M | ---- | 90.48%-11.86M | ---- |
| Advance payment increase (decrease) | 136.58%37.62M | ---- | 371.02%15.9M | ---- | -1,258.10%-5.87M | ---- | -102.99%-432K | ---- | 300.06%14.43M | ---- |
| Special items for working capital changes | -199.31%-123.49M | ---- | 449.32%124.35M | ---- | 89.97%-35.6M | ---- | -22.37%-354.9M | ---- | -169.47%-290.03M | ---- |
| Cash from business operations | -8.67%2.08B | 0.90%1.02B | 2.37%2.27B | -12.55%1.01B | 9.59%2.22B | 19.60%1.15B | -21.56%2.03B | -26.86%962.62M | 10.39%2.58B | 24.31%1.32B |
| Hong Kong profits tax paid | 24.45%-156.97M | 24.47%-156.93M | 8.73%-207.77M | 8.73%-207.77M | -51.79%-227.64M | -60.24%-227.64M | 31.06%-149.97M | 34.93%-142.06M | -40.41%-217.54M | -42.93%-218.31M |
| Other taxs | -15.48%-9.11M | -18.61%-5.67M | 28.43%-7.89M | 28.24%-4.78M | 27.16%-11.02M | 16.92%-6.67M | -19.97%-15.13M | -58.51%-8.02M | -84.75%-12.61M | -31.87%-5.06M |
| Net cash from operations | -7.17%1.91B | 7.42%853.26M | 3.81%2.06B | -13.38%794.29M | 6.49%1.98B | 12.86%917M | -20.91%1.86B | -25.65%812.54M | 8.03%2.35B | 21.13%1.09B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -9.26%8.73M | -26.34%4.3M | 25.87%9.63M | 24.03%5.83M | 167.66%7.65M | 206.32%4.7M | 29.86%2.86M | 20.77%1.54M | -33.07%2.2M | -17.04%1.27M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | 139.32%6.04M | ---- | 23.21%-15.36M | 23.21%-15.36M | ---20M | ---20M |
| Sale of fixed assets | 1,249.30%10.54M | 528.31%1.38M | -33.87%781K | -67.12%219K | -61.32%1.18M | -2.77%666K | -31.93%3.05M | -80.61%685K | 67.23%4.49M | 79.34%3.53M |
| Purchase of fixed assets | -36.08%-493.58M | -21.74%-238.51M | 25.89%-362.71M | 32.98%-195.92M | 5.18%-489.39M | -4.41%-292.36M | 9.82%-516.12M | 12.16%-280.02M | -6.10%-572.35M | -27.81%-318.79M |
| Purchase of intangible assets | -10,706.37%-16.97M | ---- | ---157K | ---- | ---- | ---- | ---15K | ---15K | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | -100.22%-155K | ---312K | -75.10%68.96M | ---- | 36,821.07%276.91M | 9,729.20%73.72M | -25.00%750K | --750K |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --40.52M | --40.52M |
| Cash on investment | ---- | ---- | ---- | ---- | 2.07%-58.76M | ---- | -50.00%-60M | ---- | 1.43%-40M | ---- |
| Net cash from investment operations | -39.32%-491.27M | -22.43%-232.84M | 24.06%-352.62M | 33.73%-190.18M | -50.42%-464.32M | -30.78%-286.99M | 47.18%-308.68M | 25.03%-219.45M | 35.15%-584.4M | 48.69%-292.72M |
| Net cash before financing | -16.78%1.42B | 2.70%620.42M | 12.33%1.71B | -4.11%604.11M | -2.24%1.52B | 6.23%630.01M | -12.24%1.55B | -25.87%593.09M | 38.47%1.77B | 141.19%800.12M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 2,493.91%6.87B | -1.45%213.4M | 4.41%265M | -44.43%216.53M | -88.52%253.81M | -82.95%389.67M | -82.73%2.21B | -58.71%2.29B | 658.89%12.8B | 228.73%5.54B |
| Refund | -2,261.79%-7.04B | 0.92%-266.86M | 46.96%-297.93M | 49.18%-269.33M | 77.51%-561.75M | 78.58%-529.99M | 67.74%-2.5B | -329.15%-2.47B | -7,402.79%-7.74B | -569.72%-576.6M |
| Interest paid - financing | 15.62%-653.03M | 1.75%-372.89M | -34.94%-773.89M | -48.55%-379.52M | -79.56%-573.49M | -133.44%-255.48M | 0.50%-319.39M | 53.07%-109.44M | 30.22%-320.98M | -9.65%-233.21M |
| Dividends paid - financing | 8.57%-473.26M | 17.50%-216.41M | 12.50%-517.62M | 0.00%-262.32M | 48.39%-591.57M | 46.67%-262.32M | -0.65%-1.15B | 1.32%-491.85M | -5.48%-1.14B | 6.39%-498.41M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -287.62%-4.25B | -293.62%-4.25B |
| Other items of the financing business | ---- | 14.46%-34.63M | ---25.47M | 0.00%-40.49M | ---- | 45.54%-40.49M | ---- | 14.49%-74.33M | -1,468.08%-22.25M | -7,948.61%-86.93M |
| Net cash from financing operations | 3.92%-1.44B | 7.16%-756.74M | 7.57%-1.5B | -4.95%-815.09M | 16.36%-1.63B | 19.79%-776.62M | -109.42%-1.94B | -285.70%-968.26M | 26.64%-928.43M | 17.21%-251.04M |
| Effect of rate | 68.33%-681K | -131.35%-3.11M | 55.18%-2.15M | 53.23%-1.35M | 25.86%-4.8M | -201.12%-2.88M | -173.99%-6.47M | -55.54%2.85M | 742.49%8.75M | 1,187.93%6.4M |
| Net Cash | -112.11%-24.57M | 35.39%-136.32M | 288.36%202.79M | -43.90%-210.98M | 72.46%-107.66M | 60.92%-146.61M | -146.46%-390.97M | -168.33%-375.17M | 6,576.66%841.46M | 1,825.43%549.08M |
| Begining period cash | 19.73%1.22B | 19.73%1.22B | -9.96%1.02B | -9.96%1.02B | -26.03%1.13B | -26.03%1.13B | 125.68%1.53B | 125.68%1.53B | 2.06%676.46M | 2.06%676.46M |
| Cash at the end | -2.07%1.19B | 34.00%1.08B | 19.73%1.22B | -17.89%804.44M | -9.96%1.02B | -15.13%979.73M | -26.03%1.13B | -6.30%1.15B | 125.68%1.53B | 78.07%1.23B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | PwC accounting firm | -- | PwC accounting firm | -- | KPMG | -- | PwC accounting firm | -- | PwC accounting firm | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.